[HTML][HTML] Neuroglial senescence, α-synucleinopathy, and the therapeutic potential of senolytics in Parkinson's disease

SJ Miller, CE Campbell, HA Jimenez-Corea… - Frontiers in …, 2022 - frontiersin.org
Parkinson's disease (PD) is the most common movement disorder and the second most
prevalent neurodegenerative disease after Alzheimer's disease. Despite decades of …

Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson's Disease

SJ Miller, CE Campbell… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease (PD) is the most common movement disorder and the second most
prevalent neurodegenerative disease after Alzheimer's disease. Despite decades of …

Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson's Disease.

SJ Miller, CE Campbell… - Frontiers in …, 2022 - search.ebscohost.com
Parkinson's disease (PD) is the most common movement disorder and the second most
prevalent neurodegenerative disease after Alzheimer's disease. Despite decades of …

[HTML][HTML] Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson's Disease

SJ Miller, CE Campbell, HA Jimenez-Corea… - Frontiers in …, 2022 - frontiersin.org
Parkinson's disease (PD) is the most common movement disorder and the second most
prevalent neurodegenerative disease after Alzheimer's disease. Despite decades of …

Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson's Disease.

SJ Miller, CE Campbell, HA Jimenez-Corea… - Frontiers in …, 2022 - europepmc.org
Parkinson's disease (PD) is the most common movement disorder and the second most
prevalent neurodegenerative disease after Alzheimer's disease. Despite decades of …

[HTML][HTML] Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson's Disease

SJ Miller, CE Campbell, HA Jimenez-Corea… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is the most common movement disorder and the second most
prevalent neurodegenerative disease after Alzheimer's disease. Despite decades of …